Coronavirus treatment reduces number of intensive care patients in clinical trial, biotech firm says
The British biotech firm Synairgen is flaunting not-yet-released clinical trial results that the company says suggest a new coronavirus treatment could reduce the number of intensive care patients, the BBC reports.
The trial results, which the BBC was not able to independently confirm, reportedly indicated that treating hospitalized patients with a protein called interferon beta cut the odds of those patients developing severe forms of COVID-19 by 79 percent, significantly reduced breathlessness, and shrunk the average hospitalization time from nine to six days.
The new drug is a special formulation of interferon beta — a viral defense mechanism that coronavirus seemingly suppresses to evade the body's immune system — delivered to the airways by a nebulizer which turns the protein into an aerosol. The hope is that the direct dose can boost an antiviral response, even in patients with weaker immune systems, BBC notes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While Synairgen is enthusiastic about the drug and plans to present its findings to medical regulators around the world in the next few days, other scientists told BBC they're reserving judgment until they see full results of the small trial, indicating that releasing the preliminary data was premature on Synairgen's part. Read more at BBC.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Cicada-geddon: the fungus that controls insects like 'zombies'
Under The Radar Expert says bugs will develop 'hypersexualisation' despite their genitals falling off
By Chas Newkey-Burden, The Week UK Published
-
'Voters know Biden and Trump all too well'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Is the Gaza war tearing US university campuses apart?
Today's Big Question Protests at Columbia University, other institutions, pit free speech against student safety
By Joel Mathis, The Week US Published
-
Amazon ending 'Just Walk Out' grocery checkout
Speed Read In its place, the company will let customers scan while they shop with Amazon Dash Cart
By Peter Weber, The Week US Published
-
Justice Department bites Apple with iPhone suit
Speed Read The lawsuit alleges that the tech company monopolized the smartphone industry
By Rafi Schwartz, The Week US Published
-
House votes to force TikTok to sell or face US ban
speed read The House passed a bill to ban TikTok on national security grounds unless it sells to a non-Chinese company
By Peter Weber, The Week US Published
-
Apple kills its secret electric car project
Speed Read Many of the people from Project Titan are being reassigned to work on generative AI
By Peter Weber, The Week US Published
-
Cellphone use may be lowering sperm count
Speed Read Electromagnetic radiation could be affecting male fertility
By Devika Rao, The Week US Published
-
Nasa reveals first findings from asteroid that could explain origins of life
Speed Read Sample from Bennu has been found to contain an abundance of water and carbon
By Jamie Timson, The Week UK Published
-
NYPD to monitor Labor Day parties using surveillance drones
Speed Read
By Justin Klawans Published
-
Elon Musk announces change to Twitter logo
Speed Read
By Justin Klawans Published